Viseven

DECEMBER 22, 2022

His article on Omnichannel approaches was published in Pharmaceutical Executive and European Pharmaceutical Manufacturer. Looking forward to 2023! We all feel excited about the new services and solutions we will deploy in 2023. And remember Pavel Klymenko? Pavel also wrote a blog post for Pharma Leaders.

Customer Service 52

Customer Service Pharmaceutical Manufacturing Communication 52

Quality Matters

JANUARY 23, 2023

They include steps championed by USP and others to increase supply chain visibility, support advanced drug manufacturing technologies, and bolster federal health agencies for the benefit of patients and public health. USP looks forward to working with all stakeholders on implementation of these important initiatives in 2023.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Biosimilars Communication 52

Quality Matters

AUGUST 3, 2023

While focuses on evaluating and establishing supplier reliability for pharmaceutical manufacturing companies and compounding pharmacies, its high-level elements of supplier qualification can also be applied to suppliers of foods and dietary supplement ingredients. josh.levin@usp.org Thu, 08/03/2023 - 15:43 Supply Chain

Packaging 52

Packaging Compounding Pharmacies Pharmaceutical Manufacturing Documentation 52

Quality Matters

SEPTEMBER 15, 2023

That way…we can do our best to communicate with you about how to best prepare a submission.” While there may be certain regulatory challenges, “there are no regulatory barriers to the adoption of continuous manufacturing, only potentially perceived ones,” asserted presenter Riley Myers, Ph.D.,

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Communication 52

GMPSOP

MAY 26, 2023

Six steps process to implement change control management Pharmaceuticals quality assurance & validation procedures GMPSOP Six steps process to implement change control management Last modified: June 3, 2023 Table of Contents “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change”.

Documentation 52

Documentation Packaging Communication Customer Service 52

GMPSOP

MAY 26, 2023

Six steps process to implement change control management Pharmaceuticals quality assurance & validation procedures GMPSOP Six steps process to implement change control management Last modified: May 28, 2023 Table of Contents “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change”.

Documentation 52

Documentation Packaging Communication Customer Service 52

GMPSOP

JULY 14, 2023

In this article, we will discuss important aspects of equipment cleaning that are required during pharmaceutical manufacturing. via visual inspection or by communication with the responsible personnel). Equipment that is used for processing medicines is one of the top sources of contamination if not cleaned regularly.

Documentation 52

Documentation Labelling Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

DECEMBER 19, 2022

in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

Pharmaceutical Technology

MARCH 22, 2023

To keep the EU’s medicine supply intact, Gupta suggests governments should adopt new pricing policies and provide further aid to mitigate the impact of rising operational costs; they should also minimise the exodus of generics manufacturers. Please check your email to download the Report.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Packaging 52

Packaging Pharmaceutical Manufacturing Communication Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 30, 2023

In this instance of contaminated cough syrups, the concern is around an excipient in the product and not the active pharmaceutical ingredient (API). It is therefore essential that all components used in the pharmaceutical manufacturing process and not just the API must be assessed and tested to full monograph specifications.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication 52